Postmenopausal osteoporosis (PMOP) is a systemic disease characterised by a decrease in bone mass and an increase in bone fragility due to a significant decrease in the level of oestrogen in postmenopausal women, manifested by bone pain, hunching, easy fracture, and a series of complications due to bone fracture, and it has become a major public health problem affecting the health of modern middle-aged and elderly women. In view of the many adverse effects of western medicine in treating PMOP, traditional Chinese medicine (TCM) treatment for postmenopausal osteoporosis has the characteristics of excellent effect, high safety, low price, and fewer adverse effects. This article reviews the relevant studies on TCM treatment of PMOP in the past 10 years, which provides certain references for clinical practice and the improvement of modern TCM theories.

Jin Shanshan, He Baorong, Chu Tianyuan, Huang Xiaoqiang. Research Progress of Chinese Medicine in Treating Postmenopausal Women with Osteoporosis. Frontiers in Medical Science Research (2023) Vol. 5, Issue 10: 92-98. https://doi.org/10.25236/FMSR.2023.051013.

[1] Wang Jie, Feng Yinfei, Yan Chunlu, et al. Advances in traditional Chinese medicine treatment of postmenopausal osteoporosis [J]. Gansu Medicine, 2023, 42(2):102-105. 

[2] Tan Simin, Chen Wenhui, LI Shuanglei, et al. Research Progress of Traditional Chinese Medicine in the Treatment of Postmenopausal Osteoporosis [J]. Popular Science & Technology, 2022, 24(278):71-74+55. 

[3] Fu Shanjiang, Ouyang Na, Sheng Zhifeng. Guideline update of Romosozumab, the new drug for postmenopausal osteoporosis women, by the American Endocrine Society in 2020 [J]. CHinese Journal Of Osteoporosis And Bone Mineral Research, 2020, 13(6):570-576. 

[4] Xia Weibo, Zhang Zhenlin, Lin Hua, et al. Chinese Society of Osteoporosis and Bone Mineral Research, Guidelines for the diagnosis and management of primary osteoporosis (2017) [J]. Chinese Journal of Osteoporosis, 2019, 25(3):281-309. 

[5] Xie Pingjin, Chai Shengting. Research Progress of Treatments of TCM for Postmenopausal Osteoporosis [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2018, 20(3): 144-148. 

[6] Xu Jinhai, Yao Min, Ye Jie, et al. Bone mass improved effect of icariin for postmenopausal osteoporosis in ovariectomy-induced rats: a meta-analysis and systematic review [J]. Menopause (New York, N. Y.), 2016, 23(10):1152-1157. 

[7] Chen Wenfang, et al. Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice [J]. The British journal of nutrition, 2011, 105(2):180-189. 

[8] Li Yan, Li Zhihang, Chen Yungang, et al. Effects of Water Decoction of Drynariae Rhizome on Adipogenic Differentiation of BMSCs of Ovariectomized Osteoporotic Rats through Wnt/β-catenin Signaling Pathway [J]. Chinese Archives of Traditional Chinese Medicine, 2019, 37(2):279-284, I0006-I0008. 

[9] Li Zhikui, Kong Junbo, Zhao Wanglin. Experimental study on effect of icariin on two-way differentiation of adipogenic and osteogenic MSCs in osteoporosis rats [J]. Chinese Journal of Immunology, 2019, 35(24):2985-2990. 

[10] Ma Wei, Pan Jing, Hu Bicheng, et al. Effect of enriching kidney and promoting blood flow TCM on Wnt signal in osteoporotic rats [J]. Chinese Journal of Osteoporosis, 2015, 21(7):820-823. 

[11] Xia Bingjiang, Xu Bing, Sun Yan, et al. The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis [J]. Journal of Ethnopharmacology, 2014, 153(1):133-141. 

[12] Cheng Wan, Xu Bing, Ying Hang, et al. The Journal of Traditional Chinese Orthopedics and Traumatology [J]. Chinese Orthopedics, 2012, 24(2):65-68. 

[13] Li Yanping, Zhang Xuehui, Peng Hui, et al. Effects of anhydroicaritin and 2"-hydroxy-3"- en-anhydroicaritin on the proliferation and differentiation of MC3T3-E1 osteoblasts [J]. Natural Product Communications, 2012, 7(11):1461-1464. 

[14] Yao Dong, Xie Xinhui, Wang Xinluan, et al. Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis--an in vitro efficacy study [J]. PLoS ONE, 2017, 7(8):e41264. 

[15] Shi Xiaolin, Wu Lianguo, Liu Kang. Guidelines for Chinese medicine diagnosis and treatment of postmenopausal osteoporosis (bone impotence) (2019 edition) [J]. The Journal of Traditional Chinese Orthopedics and Traumatology, 2020, 32(2):1-13. 

[16] Li Jianyang, Ge Jirong, Chen Juan, et al. Study on TCM syndrome characteristics of 2389 postmenopausal women at different stages of bone loss [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2021, 36(1): 389-393. 

[17] Wu Shiwei, Yan Minghui, Zhang Yulong, et al. Relationship between Chinese Medicine Syndrome and Bone Fracture in Women with Perimenopausal Osteoporosis [J]. Liaoning Journal of Traditional Chinese Medicine, 2019, 46(1): 99-101. 

[18] Chen Huiyang, Chen Kai, Chen Haipeng, et al. Research Progress on the Treatment of Postmenopausal Osteoporosis with Traditional Chinese medicine [J]. Clinical Journal of Traditional Chinese Medicine, 2020, 32(3):572-576. 

[19] Luo Yao, Chen Lanying, Guan Ziyi, et al. Effects of Cortex Eucommiae extract on bone metabolism, bone mineral density and bone microstructure in ovariectomised osteoporotic rats [J]. Journal of Chinese Medicinal Materials, 2016, 39(11):2624-2628. 

[20] Gao Weihui, Wu Fenfen, Duan Xiaoqing, et al. Effect of eucommia ulmoides and achyranthes combination on serum estradiol and bone mineral density in ovariectomized rats with osteoporosis [J]. Central South Pharmacy, 2016, 14(8):820-823. 

[21] Xie Zhancheng. Effect of flavonoids drynaria fortunei combined with whole body vibration on osteoporotic vertebral compression fractures [J]. Chinese Journal of Osteoporosis, 2017, 23(9): 1199-1203. 

[22] Shangguan Wenji, Li Zhanchun, Cheng Guangqi, et al. Effect of Drynaria Flavonoids on the Expression of Pain Mediators and Osteoporotic Pain in the Osteoporosis Model of Ovariectomized Rats [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2017, 19(3):10-12. 

[23] Yang Yanbing, Zeng Ying, Li Jinping, et al. Effects of Fructus Psoraleae-Herba Epimedii on serum IL-10 and TNF-α levels in ovariectomized rats with osteoporosis [J]. Hunan Journal of Traditional Chinese Medicine, 2016, 32(3):159-161. 

[24] Luo Zhiheng. Effects of Puerarin and Tanshinone IIA combined with VitD3 on osteoporosis induced by retinoic acid in rats [D]. Shaanxi University of Technology, 2018. 

[25] Li Chunmei. Research on Effect and Mechanism of Danshen Extract or Chuanxiong Extract on Serum Lipid and Bone in Ovariectomized Rats Fed with High Fat Diet [D]. South China University of Technology, 2013. 

[26] Xing Zhenwu. Effects of Psoralen on Notch signaling pathway of Bone Marrow Mesenchymal Stem Cells in Postmenopausal Osteoporosis Patients [J]. Acta Chinese Medicine, 2017, 32(11): 2181-2184. 

[27] Cai Hao. Experimental study on single herb rhizoma drynariae, psoralea copylifolia and the Bi-combined about prevention and treatment on bone loss in ovx rats [D]. Anhui University of Chinese Medicine, 2015. 

[28] Han Yan, Liu Na, Wu Chunlei, et al. Clinical effect of zoledronic acid combined with traditional chinese medicine in treatment of postmenopausal osteoporosis [J]. Chinese Journal of General Practice, 2015, 13(3):402-404. 

[29] Jing Yuanyuan, Xie Yanming, Jiang Junjie, et al. Meta-analysis of Duhuojishengtang in the treatment of postmenopausal osteoporosis [J]. Chinese Journal of Osteoporosis, 2021, 27(10)1: 431-1437+1475. 

[30] Zhu Qing'ao, Gu Minqi. Efficacy of Salmon Calcitonin plus Erxian Decoction(EXD)for Osteoporosis in Postmenopausal Women:A Clinical Observation [J]. Chinese Archives of Traditional Chinese Medicine, 2012, 30(12):2806-2809. 

[31] Cai Rongqi, Meng Yiling, Bi Jin, et al. The effect of the treatment in winter and summer on estradiol and melatonin level for postmenopausal osteoporosis with traditional Chinese medicine which invigorate the kidney and essence replenishment [J]. Journal of Tianjin University of Traditional Chinese Medicine, 2019, 38(2):139-142. 

[32] Ju Yang, Wu Bo, Qu Ningning. Clinical Observation of Erxian Decoction in the Treatment of Postmenopausal Osteoporosis [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2020, 22(3):199-202. 

[33] Zou Chongqi. Clinical Observation of Modified Liuwei Dihuang Decoction for Postmenopausal Osteoporosis [J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2005, 22(4): 267-268+272. 

[34] Wang Yang, Guo Wanshou, Cheng Liming, et al. The effect of Liuwei Dihuang pill on the treatment of postmenopausal osteoporosis: A systematic review and meta-analysis [J]. Chinese Journal of Osteoporosis, 2020, 26(5):663-670+688. 

[35] Hu Meisi, Zhang Wenda, Ren Yanling. Experimental study on the inhibition of lipogenesis of femur in PMOP rats with Zuo/You Gui Pills through AMPK/mTOR pathway [J]. Chinese Journal of Osteoporosis, 2020, 26(6):802-807. 

[36] Gong Yanlin. Clinical observation of Zuo Gui Wan combined with alendronate in the treatment of postmenopausal osteoporosis [J]. Journal of Practical Traditional Chinese Medicine, 2020, 36(9): 1186-1187. 

[37] Cao Junqing, Zheng Jiannan, Zhang Lin. A clinical study of oral application of Yougui Wan and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome [J]. The Journal of Traditional Chinese Orthopedics and Traumatology, 2018, 30(5):20-23. 

[38] Bian Qinglai, Zou Xiaojuan, Shen Lin. Clinical observation of Qing'e Pills in the treatment of postmenopausal osteoporosis with syndrome of kidney deficiency and blood stasis [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2018, 33(1):308-312. 

[39] Chen Fan, Wei Xu, Cui Xin, et al. The Meta-analysis and systematic evaluation of Qing’e Pill in the treatment of postmenopausal osteoporosis [J]. Chinese Journal of Osteoporosis, 2021, 27(2): 179-189. 

[40] Wu Wen, Li Dongfeng, Zhi Ximei, et al. Preventive and Therapeutic Effects of Xianling Gubao Capsules for Postmenopausal Osteoporosis [J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2005, 22(3):191-193. 

[41] Shan Meihua, Qiao Yanli, Zhang Guoni. Clinical Observation of Tenghuang Jiangu Capsule for Elderly Patients with Primary Osteoporosis of Kidney Deficiency and Blood Stasis Type [J]. Liaoning Journal of Traditional Chinese Medicine, 2023, 50(1):116-119.